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Objectives. We assessed the effects of the adenosine triphos-
phate (ATP)–sensitive potassium channel opener, nicorandil, on
ATP- and verapamil-responsive ventricular tachycardias (VTs).
Background. Adenosine- or ATP-sensitive VTs are thought to be
due to a nonreentrant mechanism, presumably delayed afterde-
polarization. We suggest that this potassium channel opener may
suppress ATP- and verapamil-sensitive VTs.
Methods. The subjects included 13 patients with idiopathic
VTs, 7 of whom had sustained VT and 6 of whom had nonsus-
tained VT. We evaluated the effects of ATP, nicorandil and
verapamil on VTs.
Results. Sustained VT: Verapamil had preventive effects on
seven VTs. Four VTs were terminated by ATP, and of these,
nicorandil terminated two and prevented exercise-induced VT in
the two others. Three ATP-insensitive VTs, which were determined
to be due to a reentry by an electrophysiologic study, were not
terminated by nicorandil. Nonsustained VT: All six VTs were
inhibited by ATP, and five of these were suppressed by nicorandil.
Verapamil inhibited four of the five VTs. QT intervals and the
corrected QT intervals were significantly shortened by nicorandil.
Conclusions. Nicorandil suppresses ATP- and verapamil-
responsive VTs. One of the mechanisms of suppression by nic-
orandil might be related to a reduction of calcium in the myocar-
dium, because it reduces the action potential duration.
(J Am Coll Cardiol 1998;32:1377–83)
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It is well known that potassium channel blocking agents inhibit
reentrant arrhythmias because of prolongation of the refrac-
toriness in the reentrant circuit. However, potassium channel
blockers are also known to induce torsade de pointes. Thus,
closing potassium channels may induce various arrhythmias
because potassium channels in cardiac cells are related to
many phenomena, including rest potential, repolarization and
slow diastolic depolarization. For example, inhibition of the
background inwardly rectifying K6 current (IK1) induces slow
diastolic depolarization, which in turn causes abnormal auto-
maticity (1). If IK1 and the delayed rectifier K6 current (IK)
are closed, the action potential duration (APD) is prolonged,
and this leads to early afterdepolarization (2). The APD
prolongation also increases calcium current into cells, and that
may induce delayed afterdepolarization. Besides these factors,
inhibition of IK1 makes the rest potential depolarize, and that
depresses sodium current, which may lead to inducing reentry.
Consequently, from the aforementioned events, the potassium
channel opener may suppress various arrhythmias. One exper-
imental study has reported that pinacidil suppressed delayed
afterdepolarization caused by ouabain, abnormal automaticity
using barium dichloride and early afterdepolarization induced
by Ca21 channel agonist Bay K 8644 or Ketanserin (3).
However, the efficacy of the potassium channel opener on
nonreentrant arrhythmias has not been reported clinically,
except for a few reports involving long QT syndrome (4,5).
One reason for this is that it is difficult to determine the
mechanism of clinical arrhythmias. Adenosine triphosphate
(ATP)–sensitive ventricular tachycardias are suggested to be
due to delayed afterdepolarization because (1) they are exac-
erbated by exercise or catecholamine; (2) they are suppressed
by beta-adrenergic blocking agents and calcium antagonists;
and (3) their electrophysiologic findings do not coincide with
reentry (6–8). The aim of this study was to assess the efficacy
of nicorandil on idiopathic VT. In addition, to clarify the
mechanism of clinical VTs, we compared the efficacy of ATP
and verapamil on nicorandil-sensitive VTs.
Methods
Subjects
We studied 13 consecutive patients (7 men and 6 women,
age 38 6 13 years) with VT in whom no underlying heart
disease was observed. Seven had sustained VT and six had
nonsustained VT. Nonsustained VT was defined as three or
more consecutive ventricular premature contractions (VPCs)
that lasted ,30 s. All patients gave written informed consent,
and the study was approved by the Showa University School of
Medicine.
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On the basis of the VTs, we evaluated drug efficacy in 13
patients with VT. All patients underwent treadmill exercise
testing using the conventional Bruce protocol.
Drug Testing for Sustained VT
Electrophysiologic study. Electrophysiologic study of the
patients with VT included assessment of baseline conduction
intervals and characteristics of sinus node function and atrio-
ventricular node conduction in the anterograde and retrograde
directions. In the absence of either spontaneous VT or VT
initiation during atrial stimulation studies, VT induction was
undertaken using one to three ventricular extrastimuli and
ventricular burst pacing at the right ventricular (RV) apex and
outflow tract. If VT was not induced, isoproterenol infusion
(0.01 to 0.02 mg kg21 min21) was initiated and the protocol was
repeated. If VT could be reproducibly induced, we assessed the
efficacy of three drugs using the following procedure.
Administration of drugs. In all individuals any cardioactive
drugs were discontinued for a period equal to at least five drug
half-lives before beginning the studies, and the test drugs were
then administered.
Adenosine triphosphate. Adenosine triphosphate was ad-
ministered as bolus intravenous injections of increasing doses
(0.2, 0.3 and 0.4 mg kg21) after VT had been sustained for at
least 30 s. If the tachycardia did not terminate within 2 min of
the initial dose (0.2 mg kg21), the dose was increased until it
did, or until the maximal dose of 0.4 mg kg21. If the ATP
injection terminated VT, the reproducibility of the effect was
assessed by administration of the same ATP dose on a second
occasion.
Nicorandil. The effect of nicorandil on VT was assessed
after ATP testing. Nicorandil (12 to 18 mg) was administered
intravenously over 3 min during VT.
Verapamil. On a separate day, or 40 min after nicorandil
administration, 10 mg of verapamil was infused slowly over
3 min during VT. When possible, assessment of prevention of
VT by verapamil was evaluated by repeating the extrastimulus
or pacing induction procedure.
The agents were considered effective in patients with sus-
tained VT when the tachycardia was terminated or suppressed.
We considered as ATP sensitive one patient whose tachycardia
was markedly slowed (cycle length prolonged by 15%) but not
terminated by ATP.
Drug Testing for Nonsustained VT
Electrophysiologic study was performed in all of the pa-
tients with nonsustained VT by the same methods as in
sustained VT. Because sustained VTs were not induced in all
patients, the efficacy of drugs was evaluated as follows. Elec-
trocardiograms (ECGs) were recorded for .30 min, and signs
of arrhythmia were observed in well-rested patients with
nonsustained VTs. When the condition of a patient was stable
with few VTs (,10 nonsustained VTs min21), isoproterenol
loading (0.01 to 0.02 mg kg21 min21) was performed. If
isoproterenol infusion suppressed the tachycardias, we ex-
cluded the patients from this study. When the arrhythmias
increased, ATP at 0.2 to 0.4 mg kg21 was administered by rapid
intravenous infusion, and 3 min later nicorandil (12 mg) was
infused intravenously over 3 min. The ECGs were then ob-
served for 40 min. Because the half-life of nicorandil is ;8 min,
at 40 min after the nicorandil infusion, verapamil (10 mg) was
infused intravenously over 3 min. The drugs were considered
effective when a 50% decrease in the arrhythmias was seen, as
compared with preadministration values. The efficacy of the
drugs was evaluated by a reduction of couplets and nonsus-
tained VTs, because couplets of VPCs sometimes increased
despite a decrease in nonsustained VTs. The average arrhyth-
mia that occurred within 1 min before ATP administration was
compared with the average arrhythmia after administration.
We also compared the values in a 10-min period after nicoran-
dil. Thirty-minute periods after verapamil injection were com-
pared with preadministration values.
QT Intervals
We investigated the changes in QT intervals and the
corrected QT interval (QTc) before and after nicorandil
administration in 12 patients in whom ECGs were recorded
(paper speed 400 mm s21). QT intervals were measured at the
recording site showing the longest QT interval by two physi-
cians, and QTc intervals were calculated according to the
Bazett formula (QTc/=RR).
Measurement of Serum Concentration of
Nicorandil
The serum concentration of nicorandil was measured 5 min
after the administration of 12 mg of nicorandil using high-
performance liquid chromatography at Mitsubishi-yuka BCL
Inc. (Tokyo, Japan).
Statistical Analysis
Results are expressed as the mean value 6 SD. Repeated
measures analysis of variance followed by the Scheffe´ F test
were used to compare measurements made before and after
serial drug administration.
Abbreviations and Acronyms
APD 5 action potential duration
ATP 5 adenosine triphosphate
LBBB 5 left bundle branch block
LV 5 left ventricular
QTc 5 corrected QT interval
RBBB 5 right bundle branch block
RV 5 right ventricular
VPC 5 ventricular premature contraction
VT 5 ventricular tachycardia
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Results
Sustained VT. As shown in Table 1, nicorandil was effec-
tive in four of the seven patients with sustained VT, who were
then classified as having nicorandil-sensitive sustained VT.
Nicorandil-sensitive sustained VTs had either an inferior axis
exhibiting left bundle branch block (LBBB) morphology (n 5
2) or right bundle branch block (RBBB) morphology (n 5 2).
The origin of VTs with an LBBB pattern was located in the RV
outflow tract, and that of VTs with an RBBB pattern was in the
left ventricular (LV) base. Three of four VTs were induced by
exercise testing. In the patient whose VT was not induced,
VPCs were exacerbated by exercise testing. In addition, all VTs
were induced by ventricular extrastimulation. Isoproterenol
infusion induced spontaneous VT in one patient (T.S.) and
facilitated the other three VTs. All four VTs did not show
entrainment phenomenon by ventricular pacing from the RV
apex, RV outflow tract or LV apex. Two VTs (patients I.M.
and S.T.) were terminated by nicorandil (Fig. 1). In patient
G.T. the VT was barely induced by exercise testing after
nicorandil injection, and the VT did not last .30 s. Conse-
quently, exercise tolerance was increased (before nicorandil
5.3 metabolic equivalents after nicorandil 8.2). In patient T.S.
nicorandil suppressed the VT and VPCs induced by isoproter-
enol infusion. In four patients in whom tachycardia was
suppressed by nicorandil, ATP stopped VT in three and
remarkably slowed it in one. Verapamil suppressed VTs in all
four patients.
In contrast, nicorandil was ineffective in three of the seven
patients with sustained VT, who were then classified as having
nicorandil-insensitive sustained VT. The morphology of the
VTs was an RBBB pattern with a superior axis. Two of the
three VTs were exacerbated with catecholamines. The VTs
were induced by ventricular stimulation in the control state in
patient H.T. and under isoproterenol infusion in patients M.Y.
and H.I.T. These three VTs originated from the LV septum
and exhibited entrainment phenomenon by pacing from the
RV outflow tract. The VTs were terminated by RV stimula-
tion. The VTs were not terminated by ATP. However, vera-
pamil terminated the VTs in all nicorandil-insensitive sus-
tained VTs.
Nonsustained VT. All six nonsustained VTs had an LBBB
pattern and an inferior axis (Table 1). An electrophysiologic
study was performed in all patients. A sustained VT could not
be induced in any of them by ventricular extrastimulation.
Isoproterenol infusion facilitated nonsustained VTs in five
patients. The electrophysiologic study showed that six VTs
arose from the RV outflow tract. All six nonsustained VTs
were inhibited by ATP. Nicorandil suppressed five of the six
VTs. Verapamil also suppressed four of the five VTs tested. A
representative case with nonsustained VT that revealed an
LBBB pattern and an inferior axis is shown in Figure 2. Figure
2, A shows nonsustained VTs that were observed 45 times in a
3-min period (150 per 10 min) in the control state. The
nonsustained VT was suppressed from six times in 30 s before
administration of ATP to once in 30 s after administration of
ATP. Couplets and nonsustained VTs were suppressed from
13 times in 30 s before administration of ATP to five times in
30 s after administration of ATP (reduction rate 83% and 62%,
respectively) (Fig. 2, C). The nonsustained VTs were sup-
pressed after nicorandil administration, from 45 times in 3 min













I.M. 15 M LBBB, LIA 1 1 1 1
S.T. 38 F LBBB, LIA 1 1 1 1
G.T. 30 M RBBB, RIA 1 1 1 1
T.S. 60 M RBBB, LIA 1 1 1 1
H.T. 27 M RBBB, RSA 2 2 2 1
M.Y. 33 F RBBB, RSA 1 2 2 1
H.I.T. 38 M RBBB, RSA 1 2 2 1
Nonsustained VT†
T.O. 19 M LBBB, RIA 1 1 1 1
T.I. 47 M LBBB, RIA 1 1 1 1
U.K. 44 F LBBB, RIA 1 1 1 1
A.M. 55 F LBBB, RIA 1 1 1 NA
I.H. 42 F LBBB, RIA 2 1 1 1
H.T. 48 F LBBB, LIA 1 1 2 2
*Sustained VT: All of seven VTs (two LBBB, five RBBB pattern) had terminative or preventive effects of verapamil.
Four VTs (two LBBB, two RBBB pattern) were terminated by ATP. Nicorandil also terminated two of the four VTs and
prevented exercise-induced VT in the two remaining patients. Three ATP-insensitive VTs due to reentry were not
terminated by nicorandil. †Nonsustained VT: Six VTs (all LBBB pattern) were inhibited by ATP and five of the six VTs
were suppressed by nicorandil. Verapamil also suppressed four of the five VTs that were tested. ATP 5 adenosine
triphosphate; F 5 female; LBBB 5 left bundle branch block pattern; LIA 5 left inferior axis; M 5 male; NA 5 (data)
not available; RBBB 5 right bundle branch block pattern; RIA 5 right inferior axis; RSA 5 right superior axis;
Sens. 5 sensitivity.
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before administration to 17 times in the same period after
administration (before administration 150 times in 10 min;
after administration 60 times in 10 min; reduction rate 60%)
(Fig. 2, C). As shown in Figure 2, B, 40 min later nonsustained
VT returned to the control level, and the VTs were suppressed
from 83 to 6 times in a 5-min period after verapamil adminis-
tration (before administration 166 in 10 min; after postadmin-
istration 12 times in 10 min; reduction rate 93%) (Fig. 2, C).
Figure 3 shows the efficacy of nicorandil and verapamil on
the arrhythmias in all patients with nonsustained VT. The top
panel illustrates a time course of couplets and nonsustained
VTs that were nicorandil sensitive. The arrhythmias were
reduced significantly by nicorandil (before nicorandil 141 6 99
in 10 min; after nicorandil 34 6 40 in 10 min; p , 0.05), and
then reappeared 30 min later (68 6 62 in 10 min). The
arrhythmias were reduced again after verapamil (4 6 4 in
10 min). As shown in Figure 3 (bottom panel), verapamil
suppressed .50% of the arrhythmias in four of four patients
with nicorandil-sensitive nonsustained VT who were tested.
One VT (patient H.T.) was not suppressed by nicorandil and
verapamil, although ATP suppressed it.
QT intervals. We investigated changes in ECG records of
QT intervals before and after nicorandil administration,
using a paper speed of 400 mms21. The results (Fig. 4) are
Figure 1. Termination of sustained VT by nicorandil. Ventricular
tachycardia with an LBBB pattern and a left inferior axis was induced
by RV stimulation under isoproterenol provocation. Ventricular tachy-
cardia was gradually slowed and terminated by injection of 5.2 mg
nicorandil.
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from 10 patients who underwent isoproterenol loading and
two patients without isoproterenol. The open circles in
Figure 4 represent eight patients with nicorandil-sensitive
VT and the crosses represent four patients with nicorandil-
insensitive VT. In all 12 patients the RR intervals did not
change after nicorandil (control vs. nicorandil: 514 6 71 vs.
522 6 86 ms; p 5 NS), although both the QT and QTc
intervals were significantly reduced, from 349 6 45 to 333 6
49 ms (p , 0.05) and from 487 6 43 to 461 6 49 (p , 0.01),
respectively. A similar trend was also seen in the patients in
whom nicorandil was effective (control vs. nicorandil: RR—
515 6 73 vs. 511 6 67 ms, p 5 NS; QT—359 6 50 vs. 339 6
50 ms, p , 0.05; QTc—500 6 46 vs. 474 6 51, p , 0.05).
However, no significant difference was seen in the three
indexes in patients in whom nicorandil was not effective
(control vs. nicorandil: RR—511 6 76 vs. 545 6 125 ms, p 5
NS; QT—328 6 27 vs. 320 6 52 ms, p 5 NS; QTc— 460 6
15 vs. 434 6 38, p 5 NS).
Serum concentration of nicorandil. The serum concentra-
tion of nicorandil in six patients, three of whom had nicorandil-
sensitive VTs and three of whom had nicorandil-insensitive
VTs, were 282 6 210 ng ml21. There was no difference in the
serum concentrations between the nicorandil-sensitive and the
nicorandil-insensitive groups (273 6 244 vs. 291 6 224 ng
ml21, p 5 NS).
Discussion
The results of this study revealed that nicorandil suppresses
certain idiopathic VTs.
Ventricular tachycardias. The characteristics of the
nicorandil-sensitive sustained VTs were induction by exercise,
spontaneous onset or facilitation during isoproterenol, absence
of entrainment and suppression by ATP and verapamil. Previ-
ous studies have shown that adenosine- or ATP-sensitive VTs
Figure 2. Efficacy of ATP, nicorandil and verapamil on nonsustained
VTs in a representative case. The VT revealed an LBBB pattern and
an inferior axis. (A) Nonsustained VTs that were observed 45 times in
a 3-min period (150 per 10 min) in the control state. An ATP bolus
injection was performed between calibrations in line 8. Nicorandil
injection started at calibration in line 11. The nonsustained VT was
suppressed from six times in 30 s before ATP administration to once in
30 s after ATP administration. Couplets and nonsustained VTs were
suppressed from 13 times in 30 s before ATP administration to five
times in 30 s after ATP administration (reduction rate 83% and 62%,
respectively, C). The nonsustained VTs were suppressed after nicoran-
dil administration, from 45 times in 3 min before administration to 17
times in the same period after administration (before administration
150 times in 10 min; after administration 60 times in 10 min; reduction
rate 60%; C). (B) Forty minutes later nonsustained VT returned to the
control level, and the VTs were suppressed from 83 times to 6 times in
a 5-min period after verapamil administration (before administration
166 in 10 min; after administration 12 times in 10 min; reduction rate
93%; C).
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do not result from reentry, but are presumed to be due to
delayed afterdepolarization (6–9). Adenosine antagonizes the
effects of beta-adrenergic agonists in ventricular cells because
it inhibits the activation of adenylate cyclase by binding to P1
purinergic receptors. This may inhibit calcium current and
abolish triggered activity. Recent reports suggest that adeno-
sine may increase ATP-regulated K6 current (10, 11). This
may in turn result in a decrease in calcium current owing to a
reduction of the APD and suppress triggered activity. Exoge-
nous ATP immediately metabolizes to adenosine, so ATP
works in the same way as adenosine. Besides this, it has been
reported recently that ATP enhances IK conductance through
the P2 purinergic receptor in atrial cells, and a similar phe-
nomenon is presumed to occur in ventricular cells (12). We
therefore consider that these factors may be related to the
effects of ATP. In this study nicorandil-sensitive VT was also
inhibited by ATP and verapamil, and the other results revealed
delayed afterdepolarization as the mechanism of nicorandil-
sensitive VTs. Another experimental study reported that the
potassium channel opener, pinacidil, reduces APD and sup-
presses delayed afterdepolarization caused by ouabain (3). We
consider that nicorandil was effective in patients in a similar
Figure 3. The efficacy of nicorandil and verapamil on nonsustained
VTs. (Top) Time course of couplets and nonsustained VTs in five
patients who had nicorandil-sensitive nonsustained VT. The arrhyth-
mias were reduced significantly by nicorandil (before nicorandil: 141 6
99 in 10 min; after nicorandil: 34 6 40 in 10 min; p , 0.05), and then
reappeared 30 min later (68 6 62 in 10 min). The arrhythmias were
reduced again after verapamil (4 6 4 in 10 min). (Bottom) Percentage
of inhibition of the arrhythmias by drugs. Verapamil suppressed .50%
of the arrhythmias in four of four patients with nicorandil-sensitive
nonsustained VT who were tested. One VT (patient H.T.) was not
suppressed by nicorandil and verapamil, although ATP suppressed it.
Figure 4. Effect of nicorandil on QT intervals. (Open circles) Eight
patients with nicorandil-sensitive VT. (Crosses) Four patients with
nicorandil-insensitive VT. In all 12 patients the RR intervals did not
change after nicorandil (p 5 NS), although both the QT and QTc
intervals were significantly reduced. A similar trend was also seen in
the patients in whom nicorandil was effective (control vs. nicorandil:
RR—515 6 73 vs. 511 6 67 ms, p 5 NS; QT—359 6 50 vs. 339 6
50 ms, p , 0.05; QTc—500 6 46 vs. 474 6 51, p , 0.05). However, no
significant difference was seen in the three indexes in patients in whom
nicorandil was not effective (control vs. nicorandil: RR—511 6 76 vs.
545 6 125 ms, p 5 NS; QT—328 6 27 vs. 320 6 52 ms, p 5 NS;
QTc—460 6 15 vs. 434 6 38, p 5 NS).
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manner. The fact that QT intervals were reduced in the
patients supports this belief. In contrast, nicorandil-insensitive
sustained VTs had ATP insensitivity and verapamil sensitivity.
The mechanism of the VTs was suggested to be reentry
because of the induction and termination by ventricular stim-
ulation and the presence of the entrainment phenomenon.
Nonsustained VTs showing an LBBB pattern with an inferior
axis arise from the RV outflow tract. These arrhythmias have
the same characteristics as ATP- or adenosine-sensitive sus-
tained VTs, and the mechanisms of the arrhythmias are
suggested to be triggered activity (9,13,14). In this study six
nonsustained VTs also arose from the RV outflow tract, and all
of them had ATP sensitivity.
Nicorandil sensitivity was also seen in all but one patient.
The exception had ATP sensitivity, nicorandil insensitivity and
verapamil insensitivity. This may be because ATP has multiple
effects on cardiac cells, as compared with nicorandil and
verapamil. Some clinical reports have revealed that nicorandil
abolished early afterdepolarization in long QT syndrome.
However, to our knowledge this is the first report of the effects
of nicorandil on idiopathic VTs. Our clinical study suggests
that nicorandil, in a manner similar to that of ATP, is helpful
in determining the initiating factor of ventricular arrhythmia.
Nicorandil is effective for a longer period, and determination
of its effectiveness is easier than that of ATP.
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